Carbamylation may turn protective cathelicidins into tissue-damaging molecules
Human LL-37, a cathelicidin peptide, may retain bacterial killing while a defined modification at its amino end increases host-cell damage. Too little modified peptide in the living organism, or no effect of selectively replacing it, would reject the mechanism.
Stage of verification
- Hypothesis published2026-09-30
- Indirect evidenceAssessed at 5 of 10
- Direct testAwaited
Map of the hypothesis
Hover over an icon or tap it to see its name.
Where in the body
Ageing mechanism
Kind of knowledge gap
A double ring marks the main placement where a group contains several values.
Target map
Every target of every published hypothesis, each with the actions a hypothesis can propose on it. The targets and the actions of this hypothesis are drawn solid.
Metabolism and energy
Cathelicidin carbamylation
Chemical modification of cathelicidin peptides by cyanate that can change their antimicrobial activity, cell recruitment and cytotoxicity
Where this hypothesis actsCathelicidins released by myeloid cells into tissue with increased cyanate formation
Hypotheses on this target 1
Inhibition1
Activation
Function preservation
Supplementation
Feedback restoration
Direct measurement
What is proposed
Inhibition
Limit carbamylation that produces tissue-damaging cathelicidin forms
With whatNot stated in the record
HowNot stated in the record
Possible result
Possible reduction in tissue damage while retaining antimicrobial protection
From the recordПоэтому сохранение памяти вместе с ограничением карбамилирования может уменьшить повреждение при сохранении защиты.
Immune response
Antimicrobial memory
An inherited cellular programme that supports rapid destruction of microorganisms
Where this hypothesis actsHaematopoietic stem cell inflammatory memory before repeated infectious episodes
Hypotheses on this target 2- Inhibition
- Activation
- Function preservation2
Clearance restoration
Immunosuppression- Feedback restoration
Rhythm restoration
What is proposed
Function preservation
Preserve protective memory while limiting cathelicidin carbamylation
With whatNot stated in the record
HowKeep memory intact while restricting the subsequent chemical modification of its peptide products
Possible result
Possible retention of antimicrobial protection with less tissue damage
From the recordПолное стирание памяти одновременно уменьшает образование полезного предшественника и его токсичных производных.
All targets of the lab
Every target read from the published hypotheses, each kind around its pictogram. A larger mark means more hypotheses act on that target. Point at a mark and the actions proposed on it branch out of it.
Solid and named: the targets of this hypothesis
Explore in depth
The logic
The train of thought that ends in this hypothesis. Each stage is the reason the next exists. The master question narrows to a goal, the goal to an unknown nobody has closed, the unknown to the hypothesis proposed here. Every step below says what it rests on and what carries it.
A response that helps fight one infection might also leave tissues paying a longer-term price. The unexpected move is to locate that price in a protective molecule chemically altered after its production, rather than solely in the cells that remember earlier inflammation. This pipeline generated the proposal that preventing that alteration could preserve rapid protection while reducing damage; that combined benefit has not been measured in the supplied material.
- Protective inflammatory memory is proposed to sustain the supply of infection-fighting cathelicidins from myeloid cells.
- Cyanate in the surrounding tissue is proposed to chemically alter the released molecules after their production.
- An alteration at a particular location is proposed to change LL-37 from a protective molecule into one that still kills bacteria but causes greater harm to host cells.
- Accumulation of that particular altered form is proposed to increase tissue damage even when total secretion and early infection burden are unchanged.
- Preventing formation of that altered form is proposed to reduce damage while leaving protective memory and bacterial killing available.
A cleaning fluid might still remove dirt after reacting with something on a surface, yet become more damaging to the surface itself. Preventing that reaction could retain the cleaning action.
Where the picture breaks: Immune protection involves living cells, changing infection levels and several interacting molecules. The picture does not establish that the proposed altered molecule occurs in sufficient amounts in tissue or that preventing its formation preserves infection defence.
- Master questionstep 01 of 04
Ageing processes may reinforce one another, so changing a shared cause might benefit several body systems at once.
Rests on: The goal takes interacting ageing processes and a potentially shared cause as the starting point for finding broadly useful interventions.
AssumptionIt assumes that a shared cause can be targeted precisely enough to produce benefits across several systems; the supplied goal does not establish such a target.
- Goal pillarstep 02 of 04
Restoring function across the body should come with a limited delayed cost.
Rests on: The master question seeks benefits across several systems, but does not identify delayed costs of restoration.
AssumptionIt assumes that delayed harm from restoration is a relevant constraint on the broad benefits sought by the master question.
- Gap questionstep 03 of 04
Inflammatory memory, a persistent change in how cells respond after earlier inflammation, might contain separable contributions to chronic damage and rapid infection defence in blood-forming stem cells, the cells that produce blood and immune cells. Independently changing this memory and the surrounding tissue before repeated infections is proposed as a way to separate those contributions.
Rests on: The preceding goal names delayed costs, but supplies no connection between those costs and memory in blood-forming stem cells.
LeapThe missing bridge is evidence or an explicit rationale connecting delayed costs of body-wide restoration to these cells' inflammatory memory and its proposed damaging and protective contributions.
- Hypothesisstep 04 of 04
Protective memory is proposed to supply cathelicidins, infection-fighting molecules released by myeloid cells, a family of immune cells. In the surrounding tissue, cyanate, a reactive chemical, is proposed to drive carbamylation, a chemical alteration of a molecule's amino groups. The location of that alteration is proposed to determine whether protection is retained while harm increases, making selective prevention of the alteration an alternative to erasing memory.S5
Rests on: The previous question supplies the distinction between cell memory and tissue surroundings. S5, published in Innate Immunity in 2016, found that one altered form of LL-37, a human cathelicidin, retained bacterial killing, lost attraction of neutrophils, a type of immune cell, and gained the ability to rupture red blood cells in a laboratory test. That supports a location-dependent change in function, but does not establish the connection to protective memory, sufficient amounts in living tissue, or a benefit from preventing the alteration.
Supported by literature
What is carried, and what is not. Of the five proposed mechanism links, screened evidence directly supports the functional switch in the third: S5, in Innate Immunity in 2016, found retained bacterial killing alongside greater red-blood-cell rupture for one altered form, but did not establish tissue injury or the memory connection. S3, in Frontiers in Immunology in 2021, found increased bone-matrix breakdown involving complexes of altered LL-37 and antibodies, proteins that bind particular targets; this supports a separate route to damage, not the proposed direct sequence, which no supplied source establishes end to end.S5S3
Where the reasoning is carried by something unstated · 3
- Master question. It assumes that a shared cause can be targeted precisely enough to produce benefits across several systems; the supplied goal does not establish such a target.
- Goal pillar. It assumes that delayed harm from restoration is a relevant constraint on the broad benefits sought by the master question.
- Gap question. The missing bridge is evidence or an explicit rationale connecting delayed costs of body-wide restoration to these cells' inflammatory memory and its proposed damaging and protective contributions. Establish the missing link before relying on this step.
How a result here could mislead · 3
- A change in the total amount of altered LL-37 could be credited to the particular harmful form even if alterations at other locations account for the change. The supplied findings do not support treating all altered forms as functionally interchangeable. What closes it: The proposed mass spectrometry, a method for identifying and measuring molecules through their mass and charge, must distinguish and quantify the exact forms. Total LL-37 secretion and early infection burden must also be matched, as the prediction requires.
- Damage caused by adding a prepared altered molecule could be mistaken for evidence that naturally occurring amounts cause the same damage. Conversely, failure to reduce damage could be mistaken for a failed mechanism when the intervention never sufficiently reduced the targeted form. What closes it: Measure the exact form in the relevant tissue, verify its reduction, and replace it at the measured concentration. The supplied specification gives no numerical concentration or criterion for sufficient removal; those criteria must be fixed before interpreting the result.
- Damage involving altered LL-37 could be attributed to direct harm from the molecule when binding by antibodies supplies the damaging route. S3, in Frontiers in Immunology in 2021, found enhanced bone-matrix breakdown through such complexes, but did not establish direct tissue-cell injury from the proposed specific form.S3 What closes it: The comparison must separate the altered molecule acting alone from the same molecule with relevant antibodies present, and measure the claimed direct cell injury alongside the tissue outcome.
What would make this wrong. The proposed mechanism would fail in the tested setting if the specific altered LL-37 form were absent or below the amount needed to cause the claimed damage, or if verified selective removal and replacement at its measured tissue concentration left damage unchanged while secretion and early infection burden remained matched. If removing it reduced damage but also impaired infection defence, the proposed separation of harm from protection would fail even if the altered molecule contributed to injury.
What it would change. If the proposed sequence held, part of the cost of retained infection defence would arise from what the tissue does to protective molecules after their production. Work seeking a shared intervention against ageing-related damage would then have a reason to test selective prevention of that chemical change while preserving memory. Even a positive result in human cell or tissue models would not establish longer life, benefits across organs, or effects during repeated infections in ageing bodies. Transfer to old mice would remain unestablished because their cathelicidin differs from human LL-37 and requires separate confirmation of both chemistry and function.
Sources read · 6
Anti-LL37 Antibodies Are Present in Psoriatic Arthritis (PsA) Patients: New Biomarkers in PsA. · Frontiers in immunology · 2018
“Anti-carbamylated/citrullinated-LL37 antibodies are present in PsA SF/plasma and, at lower extent, in psoriasis plasma, but not in controls.”
Does not settle: The source does not establish that carbamylation changes LL37 antimicrobial activity, cell recruitment, or cytotoxicity; identify modification sites; show cyanate-driven tissue carbamylation; or test effects on protective memory or tissue damage.
A Novel Biological Role for Peptidyl-Arginine Deiminases: Citrullination of Cathelicidin LL-37 Controls the Immunostimulatory Potential of Cell-Free DNA. · Journal of immunology (Baltimore, Md. : 1950) · 2018
“In contrast, carbamylation of the peptide (homocitrullination of Lys residues) had no effect.”
Does not settle: Источник не оценивает противомикробную активность, привлечение клеток, цитотоксичность, тканевое повреждение, роль цианата в тканях или последствия сохранения либо стирания памяти.
Anti-Carbamylated LL37 Antibodies Promote Pathogenic Bone Resorption in Rheumatoid Arthritis. · Frontiers in immunology · 2021
“CarLL37-IgG immune complexes enhanced the ability of monocytes to differentiate into osteoclasts and potentiated osteoclast-mediated extracellular matrix resorption.”
Does not settle: Источник показывает, что карбамилированный LL37, высвобождаемый нейтрофильными внеклеточными ловушками, связан с патогенным иммунным ответом и резорбцией внеклеточного матрикса при ревматоидном артрите. Он не устанавливает, что цианат в тканевой среде непосредственно карбамилирует выделенные миелоидными клетками кателицидины, не сравнивает конкретные положения модификации по противомикробной активности, привлечению клеток и цитотоксичности и не оценивает сохранение или стирание защитной памяти.
Generation of Monoclonal Antibodies Specific for Native LL37 and Citrullinated LL37 That Discriminate the Two LL37 Forms in the Skin and Circulation of Cutaneous/Systemic Lupus Erythematosus and Rheumatoid Arthritis Patients. · Antibodies (Basel, Switzerland) · 2020
“While antimicrobial activity is reduced by both PTMs, carbamylation increases the LL37-driven neutrophils chemotaxis, whereas citrullination decrease it”
Does not settle: The source does not establish tissue damage or cytotoxicity, modification-site-specific functional tradeoffs, effects on protective memory, or whether limiting carbamylation preserves protection while reducing damage.
Carbamylated LL-37 as a modulator of the immune response. · Innate immunity · 2016
“Even though carbamylation at this site did not affect the bactericidal properties of the peptide, LL-37 C1 lost the ability to function as a chemoattractant for neutrophils. Concurrently, LL-37 C1 gained significant RBC-lysing capacity; indeed, it was almost 3-fold more cytotoxic than native LL-37 in a hemolytic assay.”
Does not settle: Источник исследует модифицированные формы LL-37 в экспериментальных условиях и не устанавливает связь с защитной памятью, происхождение LL-37 от миелоидных клеток в ткани, частоту такой модификации in vivo или то, что ограничение карбамилирования уменьшит повреждение при сохранении защиты.
[The value of a low-protein diet and ketoanalogues of essential amino acids in the сontrol of protein carbamylation and toxic effects of urea in chronic kidney disease]. · Terapevticheskii arkhiv · 2021
“The indirect effects of increased urea levels are associated with carbamylation reactions, when isocyanic acid (a product of urea catabolism) changes the structure and function of proteins in the body.”
Does not settle: Источник не устанавливает карбамилирование кателицидинов, участие миелоидных клеток, положение модификации или влияние на противомикробную активность, привлечение клеток и цитотоксичность.
The gap this hypothesis explains
Something is claimed here, but it rests on evidence too thin to carry weight.
Can changing blood-forming stem-cell memory separately from its surroundings reduce lasting damage while preserving protection against repeated infections?
Original wording · exactly as the pipeline generated it
Можно ли причинно разделить воспалительную память кроветворных стволовых клеток на программу хронического повреждения и программу быстрой защиты, если независимо изменять клеточную память и тканевое окружение перед повторными инфекционными эпизодами?
What this question is asking
The question concerns lasting changes in blood-forming stem cells after inflammation, and whether their harmful and protective effects can be separated. It asks what happens when those lasting changes and the surrounding tissue are altered independently before repeated infections. The comparison is whether lasting damage can decrease while the body still limits the amount of infection in the first hours and days and retains that ability across later episodes. It assumes that cell memory and the surrounding tissue could contribute to both outcomes, but the supplied sources do not establish two distinct programs that can be independently controlled.
- Blood-forming stem cells
- Cells that can maintain their own population and produce the different types of blood cells, including immune cells. Lasting changes in these cells are the proposed starting point of the question.
- Progenitor cells
- Descendants of stem cells that produce a more restricted range of cell types. S2 discusses them together with blood-forming stem cells, so its statement is not limited to stem cells alone.
- Inflammation
- A collection of bodily responses to infection or injury. In this question, it is the earlier condition proposed to leave lasting changes in blood-forming cells; inflammation and lasting tissue damage are not interchangeable measurements.
- Cell memory or inflammatory memory
- A lasting alteration in how a cell responds after an earlier exposure, rather than conscious memory. Here it names a proposed persistent state, not an already identified single mechanism with proven harmful and protective components.
- Cellular program
- A coordinated pattern of activity within cells. Calling damage and protection separate programs does not establish that they have distinct causes or can be independently switched off.
- Tissue surroundings
- Nearby cells and the local conditions and signals that influence a cell. For blood-forming stem cells, the supplied sources discuss supporting surroundings within bone marrow.
- Bone marrow
- Tissue inside bones where blood cells are produced. It contains both blood-forming cells and cells that support and regulate them.
- Mesenchymal stromal cells
- A class of supporting cells that can release signals affecting other cells. In S7, their released signals are reported to leave blood-forming stem cells prepared for a later enhanced response.
- Emergency granulopoiesis
- An increased production of granulocytes, a group of immune cells, in response to urgent demand. This is the response described in S7; increased cell production alone does not establish reduced infection or reduced lasting damage.
- Chimeric mouse model and transplantation
- A research setting in which a mouse contains introduced cells from another source; transplantation is the transfer of those cells. S7 reports a response months after that transfer, which is a different timescale from measuring infection control during its first hours and days.
- Bacillus Calmette–Guérin vaccination
- The vaccination examined in S8 for its capacity to protect against viral disease. The supplied quote describes that protection as dependent on the disease process and tissues involved.
- Cellular metabolism and regulation of gene activity
- Cellular metabolism comprises the chemical processes through which cells obtain and use materials and energy. Regulation of gene activity controls how cells use their genetic instructions; S2 reports changes in both processes, without establishing their effects on repeated infections.
- Programmed cell death
- A regulated process through which a cell is eliminated. S3 discusses its control alongside cell division, rather than directly measuring the damage-versus-protection distinction in the question.
- Causal separation
- Distinguishing what each factor actually produces, rather than merely observing that factors change together. Here the factors are lasting states within blood-forming stem cells and influences from their surroundings.
- Chronic damage and protective capacity
- Chronic damage means continuing or lasting injury; protective capacity means the ability to limit infection, including during later episodes. They are outcomes requiring defined measurements, and the supplied material provides no numerical boundaries for either.
Inflammatory memory in blood-forming stem cells and signals from their tissue surroundings contribute to chronic damage and rapid protection as potentially separable programs.
Blood-forming stem cells produce blood and immune cells, while nearby supporting cells supply signals that influence their behavior. The assumption is that lasting changes within the stem cells and signals from those surroundings help determine both continuing injury and rapid defense against infection. If that holds, separating their contributions could explain whether reducing injury also removes protection.
S7 supports a narrower claim: signals released by supporting cells can leave blood-forming stem cells prepared for an enhanced response months after transplantation in mice. S2 reports changes in both blood-forming cells and supporting cells in diabetes, and S3 describes regulation by mechanisms inside stem cells together with signals from their surroundings. These findings do not establish that inflammatory memory causes both chronic damage and rapid protection, that these are distinct programs, or that their contributions have been independently separated before repeated infections.S2S3S7
The same question asked without the part nothing read establishes:
- Does independently changing lasting states in blood-forming stem cells and their surroundings affect chronic damage differently from early protection across repeated infections?
- What do lasting changes within blood-forming stem cells and signals from their surroundings each contribute to damage and protection during repeated infections?
- Damage falls and protection remains Under the question's proposed mechanism, a change would reduce the contribution to lasting injury while preserving early control of infection across later episodes. This would support functional separation under the conditions examined, although it would not by itself establish two distinct internal programs.
- Damage and protection fall together The change would reduce lasting injury but also weaken early control of infection or the ability to respond to later episodes. The apparent benefit from reduced damage would therefore come with a loss of defense; this outcome alone would not prove that a single internal program causes both effects.
- The outcome depends on the surroundings The same lasting cell state would produce different outcomes in different tissue surroundings. Protection or damage could then not be attributed to cell memory alone, and an effect observed in one setting would not establish the same tradeoff in another.
In the mechanism proposed by the question, an earlier inflammatory episode changes blood-forming stem cells, which can then change the supply or behavior of cells involved in later defenses. Signals from surrounding tissue could also influence these responses, making it difficult to attribute an outcome to memory inside the cells alone. If the same lasting change supports both damage and protection, removing it could reduce damage while weakening early control of infection. If those effects are separable, reducing damage would not necessarily require losing protection, but that separation is not demonstrated in the supplied evidence.
Узлы RL-1 описывают память предшественников и тканевых лимфоцитов; измерения RL-2 отслеживают состояния, но разделимость повреждения и защиты экспериментально не установлена.
После снижения воспаления инфекционная нагрузка ограничивается в первые часы и сутки; повторные эпизоды сохраняют защитный резерв в заданных границах.
Неизвестно, устраняет ли изменение памяти общий источник повреждения или одновременно расходует необходимый защитный резерв; причинность клеточной программы и окружения остаётся неразделённой.
The mechanism it proposes
The engine's own statement of the hypothesis, in full.
Функциональный компромисс возникает при химическом превращении продуктов защитной памяти в повреждающие молекулы уже после их синтеза. Предполагается, что тканевая среда с повышенным образованием цианата карбамилирует выделяемые миелоидными клетками кателицидины. Конкретное положение модификации определяет соотношение противомикробной активности, привлечения клеток и цитотоксичности. Поэтому сохранение памяти вместе с ограничением карбамилирования может уменьшить повреждение при сохранении защиты. Полное стирание памяти одновременно уменьшает образование полезного предшественника и его токсичных производных.
Testing and possible results
The prediction that would tell it apart
A hypothesis that predicts what its rivals predict is not worth running an experiment over. This is the observation on which this one differs.
При одинаковой секреции кателицидина и одинаковой ранней инфекционной нагрузке повреждение ткани определяется долей конкретных карбамилированных форм. Химически определённая N-концевая модификация человеческого LL-37 повышает повреждение клеток хозяина при сохранении бактерицидного эффекта в подходящей модели. Ограничение образования этой формы уменьшает повреждение, а её добавление в измеренной физиологической концентрации возвращает его. Отсутствие достаточного количества модифицированного пептида in vivo или эффекта его избирательной замены опровергает механизм.
States a measurable outcome; comparing rivals needs more conditions. The prediction specifies increased host-cell damage with preserved bactericidal activity, reduced damage upon limiting the modified form, restoration upon adding it, and explicit rejection conditions. No rival prediction is supplied. Only a bench experiment would settle it.
What testing it would take
The engine's own read on whether this is testable with methods that already exist.
Химически определённые варианты пептида и масс-спектрометрия позволяют разделить эффекты отдельных мест модификации. Для начала подходят человеческие клеточные и тканевые модели. Мышиный кателицидин отличается от LL-37, поэтому перенос на старых мышей требует самостоятельного подтверждения химии и функций соответствующих производных.
Other explanations
Every other hypothesis the engine wrote for the same gap, and the observation that would separate the two.
При одинаковой секреции кателицидина и одинаковой ранней инфекционной нагрузке повреждение ткани определяется долей конкретных карбамилированных форм. Химически определённая N-концевая модификация человеческого LL-37 повышает повреждение клеток хозяина при сохранении бактерицидного эффекта в подходящей модели. Ограничение образования этой формы уменьшает повреждение, а её добавление в измеренной физиологической концентрации возвращает его. Отсутствие достаточного количества модифицированного пептида in vivo или эффекта его избирательной замены опровергает механизм.
- Rival 01 of 03What would separate them
Interleukin-6 from blood-forming stem cells may sustain organ damage while preserving defense predicts: После формирования памяти ограниченное стволовыми клетками выключение синтеза интерлейкина-6 снижает его межэпизодный уровень и последующее повреждение лёгких и почек раньше обновления зрелых миелоидных клеток. Численность, состояние хроматина и ранняя противомикробная активность этих клеток остаются сопоставимыми с контролем. Восстановление измеренного физиологического потока интерлейкина-6 возвращает повреждение. Отсутствие достаточного потока из стволовых клеток или появление эффекта только после смены потомков опровергает центральное утверждение.
- What would separate them
Molecular crowding may shift enzyme forms to preserve rapid antimicrobial defense predicts: При одинаковых количестве фермента, составе клеток и состоянии хроматина обратимое изменение доли объёма, занятого макромолекулами, меняет образование восстановительного эквивалента и раннее уничтожение микроорганизмов. Эффект возникает до изменения транскрипции. В бесклеточной реконструкции воспроизводятся направление и величина сдвига равновесия ферментных форм. Если влияние исчезает после контроля осмолярности, кислотности и вязкости либо сопровождается только изменением транскрипции, гипотеза исключённого объёма теряет поддержку.
- What would separate them
Queuosine modification may separate antimicrobial protection from inflammatory damage predicts: При одинаковом количестве матричной РНК изменение квеозиновой модификации меняет отношение синтеза выбранных защитных и повреждающих белков. Зависимость защитного белка от модификации исчезает после синонимической замены чувствительных кодонов при сохранении его аминокислотной последовательности и сопоставимых количества и стабильности матричной РНК. Такая замена восстанавливает раннюю защитную функцию после ослабления воспалительной памяти. Сохранение эффекта после замены кодонов либо отсутствие различий между защитным и повреждающим наборами белков опровергает предложенное разделение.
What stands behind it
Which of the figures above have a study behind them, which are the engine's own, and what it would take to refute the hypothesis. This audit never judges the idea.
This hypothesis states no figure and cites no study, so there is nothing here to trace.
What it would take to refute it. Nothing already retrieved carries the prediction’s terms and it names no measurement this layer can route to a public dataset, so the bench is the residual — not a finding against it.
0 citation handles extracted; 1 Europe PMC search run; 0 records examined; 0 sources stored for enrichment, 0 with full text. A citation that did not resolve is a bibliographic failure, not proof that no such paper exists, and no hypothesis is blocked by this audit.